Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of intraventricular EG-1962 versus oral nimodipine in adults with aneurysmal subarachnoid hemorrhage
MOH_2017-04-09_000313Phase 3Recruiting
- Sponsor
- Edge Therapeutics
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing Standard oral nimodipine with EG-1962 intraventricular (2 arms). Primary endpoint: Safety and efficacy of EG-1962 compared with oral nimodipine. Started Jun 2016; status: recruiting.
02
Drugs
EG-1962nimodipine
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on MOH_2017-04-09_000313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-04-09_000313.